HHS and the Surgeon General issue a warning on children’s screen use. The FDA rejects Sydnexis’ SYD-101 — despite the STAR trial meeting its primary endpoint. Hoya’s MiYOSMART iQ posts some of the strongest myopia control data ever reported.

Dr. Cary Herzberg — 40+ years in specialty optometry — on the insurance model burning doctors out, the specialty care exit ramp, and whether the profession can save itself.

Dr. Marie Homa-Palladino on Listening, Connection, and Myopia Management Done Right

Every month there’s more happening in myopia management than any one clinician can keep up with — new studies, new products, new debates. We go through the five most important stories from Q1 2026 — and we don’t hold back on the disagreements.

Dr. Cary Herzberg lays down four decades of frustration: optometry has had the data, the products, and the patients in the chair since the early 1980s — and is still, in 2026, asking how to get colleagues to start.

Twenty years ago, the myopia toolbox had one drawer: ortho-K. Today, U.S. optometrists have FDA-approved soft contacts, an approved spectacle lens, off-label low-dose atropine, and a steady drip of next-generation options coming through Health Canada first. So how do you actually decide what to put a kid in?

The Sydnexis SYD-101 FDA rejection: the data the regulator ignored, the kids it leaves behind, and what you can actually do about it.

What does it look like to build a full-spectrum myopia management program inside one of the country’s top pediatric hospitals — and what can every optometrist learn from it?

Myopia management can feel intimidating when you first start. Many clinicians worry about complex prescriptions, difficult lens designs, and whether the treatment will even work.

If we could genetically predict myopia progression… would you test every patient?

Can ortho-k really be “easy” — or are we skipping the fundamentals?

In Part 2 of this series, host Matthew Herzberg sits down with Dr. Anith Pillai and Dr. Matthew Martin to break down real trans-limbal ortho-k cases, focusing on the decisions, mistakes, and design adjustments that determine success or failure.

In Part 1 of this two-part series, host Matthew Herzberg is joined by Dr. Anith Pillai and Dr. Matthew Martin to break down trans-limbal ortho-k—what it is, what it is not, and why it’s quietly transforming how experienced clinicians approach adult, hyperopic, and high-challenge cases.

In this episode of The Myopia Mindset, host Matthew Herzberg is joined by Dr. Ashley Tucker and Dr. Kevin Chan, co-editors of Review of Myopia Management, to break down the most important myopia management stories of 2025.

In this episode Matthew Herzberg brings together a panel of leading voices in myopia management to tackle one of the most difficult—and most important—topics in pediatric care: visual hygiene.